BSEBoard Meeting6d ago · 4 Nov 2026, 05:11 pm
Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Omkar Pharmachem Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Unaudited Financial result for the quarter and half year ended on September 30, 2026 along with Limited Review Report thereof.
Omkar Pharmachem Ltd · 532167
✦ AI SummaryResults
Omkar Pharmachem Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 to consider and approve Unaudited Financial result for the quarter and half year ended on September 30, 2026 along with Limited Review Report thereof.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Omkar Pharmachem Ltd - 532167 - Board Meeting Intimation for Intimation Of The Board Meeting Of The Company Under Regulation 29(1)(A) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Attachments (1)
📄pdf
Download →
9bb0e4b5-406c-42be-b555-76e1ef12f180.pdf
View document text
L& 7
39 Ombkar DPharmachem
L 8.
Date: 04.11.2026
BSE Limited,
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai-400001
Sub: Intimation
of the Board Meeting of the Corapany
Under Regulation
29(1)(A)
of SEBI (Listing Obligations
And Disclosure
Requirements)
Regulations,
2015
Company
Scrip Code: 532167
Dear Sir(s),
Pursuant to Regulations
29(1)(a) of SEBI (LODR) Regulations
2015 notice is
hercby given that a meeting of Board of Directors of Omkar Pharmachem
Limited will be held on Saturday,
14" Day of November,
2026 at 04:30 P.M.
at the registered office of the Company inter :lia;
To consider, approve and take on record the Unaudited Financial Results of the
Company for the Quarter and half year encicd on 30" September,
2026.
Further, in continuation
to our Intimation dated September
26, 2026 regarding
closure of trading window for dealing in chares of the Company, we hereby
inform you that pursuant to the Code of Conduct to Regulate, Monitor and Report
Trading in Securities of the Company, the trading window for dealing in shares
of the Company shall continue to remain closed till November 16, 2026,
(inclusive) for all the Designated
Persons of i Company and their Immediate
Relatives.
Thanking you,
Yours faithfully,
For Omkar Pharmachem
Limited
Digitally signed by
B HAWA N BHAWANI'S GOYAL
Date: 2026.11.04
I S GOYAL 16:05:28 +05'30'
Bhawani S Goyal
(Managing
Director)
DIN: 03255804
Address: Ward No-03, Nangal Chaudhry,
Narnaul, Mahendragarh,
Haryana-123023
Off,= Il Street-1, Near Gujja ral College Cross Road, Ellisbri dge Ahmmeedca bad-380006, GJ, Ph.: 971181116
- CIN: E;gf)gr}?‘SJ‘JQGSPLCU%QTS, Email: investors.opl@gmail.com, Website: www.omkarpharmachem co.in